RAYMOND JAMES & ASSOCIATES - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 193 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$474,000
+182.1%
28,349
+143.9%
0.00%
Q1 2020$168,000
-82.0%
11,622
-58.3%
0.00%
-100.0%
Q4 2019$932,000
+73.9%
27,859
+8.9%
0.00%0.0%
Q3 2019$536,000
-38.0%
25,585
-38.4%
0.00%0.0%
Q2 2019$865,000
-28.3%
41,565
-23.0%
0.00%
-50.0%
Q1 2019$1,206,000
+8.7%
53,964
+16.3%
0.00%0.0%
Q4 2018$1,109,000
-20.8%
46,383
-9.7%
0.00%0.0%
Q3 2018$1,401,000
-3.7%
51,342
-5.1%
0.00%0.0%
Q2 2018$1,455,000
-5.8%
54,108
+11.6%
0.00%
-33.3%
Q1 2018$1,544,000
+65.0%
48,496
+96.0%
0.00%
+50.0%
Q4 2017$936,000
+63.6%
24,737
+7.2%
0.00%
+100.0%
Q3 2017$572,000
+20.9%
23,068
+0.2%
0.00%0.0%
Q2 2017$473,000
+20.7%
23,017
+27.6%
0.00%0.0%
Q1 2017$392,000
+11.0%
18,035
+4.5%
0.00%0.0%
Q4 2016$353,000
+37.4%
17,260
+0.7%
0.00%0.0%
Q3 2016$257,000
+93.2%
17,134
+39.4%
0.00%
Q2 2016$133,000
-20.8%
12,291
-0.5%
0.00%
-100.0%
Q1 2016$168,00012,3560.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 3,100,146$117,248,00040.96%
TLP GROUP LLC 1,050,000$39,711,00027.53%
Aisling Capital LLC 2,240,000$84,717,00016.74%
Foresite Capital Management III, LLC 764,824$28,926,0008.12%
AlpInvest Partners B.V. 51,498$1,948,0006.95%
Vivo Capital, LLC 643,626$24,342,0005.21%
GREAT POINT PARTNERS LLC 573,550$21,692,0003.70%
Eventide Asset Management 1,226,000$46,367,0002.42%
Palo Alto Investors LP 1,146,419$43,358,0001.87%
HAMILTON LANE ADVISORS LLC 78,846$2,982,0001.54%
View complete list of AIMMUNE THERAPEUTICS INC shareholders